ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $45,144,000 | +30.4% | 2,393,612 | -18.6% | 17.24% | +51.8% |
Q2 2019 | $34,629,000 | -13.8% | 2,942,130 | 0.0% | 11.36% | +8.6% |
Q1 2019 | $40,160,000 | +33.2% | 2,942,130 | 0.0% | 10.45% | +5.5% |
Q4 2018 | $30,157,000 | -38.4% | 2,942,130 | 0.0% | 9.90% | -8.4% |
Q3 2018 | $48,986,000 | +5.4% | 2,942,130 | 0.0% | 10.81% | +8.0% |
Q2 2018 | $46,486,000 | +24.4% | 2,942,130 | 0.0% | 10.01% | +22.9% |
Q1 2018 | $37,365,000 | +14.6% | 2,942,130 | +3.3% | 8.14% | -11.0% |
Q4 2017 | $32,600,000 | -9.5% | 2,847,130 | -3.2% | 9.15% | -7.9% |
Q3 2017 | $36,042,000 | +44.6% | 2,942,203 | +35.1% | 9.93% | +21.9% |
Q2 2017 | $24,929,000 | -26.4% | 2,177,203 | +33.6% | 8.14% | -37.4% |
Q1 2017 | $33,888,000 | +0.1% | 1,629,222 | +0.1% | 13.01% | -11.6% |
Q4 2016 | $33,869,000 | -34.8% | 1,628,328 | +2.7% | 14.72% | -39.4% |
Q3 2016 | $51,963,000 | +30.0% | 1,585,683 | -0.9% | 24.29% | -11.4% |
Q2 2016 | $39,957,000 | +27.6% | 1,600,183 | +25.2% | 27.42% | +13.2% |
Q1 2016 | $31,312,000 | +312.4% | 1,278,570 | +456.2% | 24.23% | +259.8% |
Q4 2015 | $7,593,000 | – | 229,895 | – | 6.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |